RKV — Rakovina Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Rakovina Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.474	0.808	2.81	0.897	0.436
Net Total Accounts Receivable
Net Total Receivables	0.001	0.006	0.074	0.015	0.02
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.495	0.814	3.07	1.07	0.633
Net Intangible Assets
Total Assets	0.495	0.814	8.66	6.12	5.15
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.02	0.042	0.114	0.107	0.155
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.02	0.042	0.114	0.107	1.49
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.475	0.772	8.54	6.01	3.66
Total Liabilities & Shareholders' Equity	0.495	0.814	8.66	6.12	5.15
Total Common Shares Outstanding